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Abstract
Background: Interleukin 32 (IL-32) is a pro-inflammatory cytokine induced in patients with American tegumentary
leishmaniasis (ATL) caused by Leishmania braziliensis. Here, we investigated whether IL-32 is also expressed in
patient lesions caused by L. amazonensis. In addition, we evaluated experimental L. amazonensis and L. braziliensis
infections in C57BL/6 transgenic mice for human IL-32γ (IL-32γTg) in comparison with wild-type (WT) mice that
do not express the IL-32 gene.
Results: Human cutaneous lesions caused by L. amazonensis express higher levels of IL-32 than healthy control
skin. In mice, the presence of IL-32γ promoted the control of cutaneous lesions caused by L. braziliensis, but not
lesions caused by L. amazonensis in an ear dermis infection model. In addition, IL-32γTg mice displayed less tissue
parasitism and inflammation in IL-32γTg than WT mice during the healing phase of L. braziliensis infection. Production
of antigen-specific pro-inflammatory cytokines was higher in IL-32γTg mice than in WT mice during L. braziliensis
infection but not during L. amazonensis infection.
Conclusions: Human cutaneous lesions caused by L. amazonensis express high levels of IL-32. In mice, the
presence of IL-32γ contributes to the lesion healing caused by L. braziliensis but not by L. amazonensis. Data
suggest that despite the ability for both species to induce IL-32 in humans, the connections between this
cytokine and other immune players induced by related species of parasites can lead to distinct outcomes of
the murine infections.
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Background
American tegumentary leishmaniasis (ATL) is an infec-
tious disease caused by Leishmania protozoan, affecting
the skin, oral or nasal mucosa. Brazil is one of 10 coun-
tries that together account for 70–75% of the cases of
tegumentary leishmaniasis in the world [1]. Leishmania
amazonensis and Leishmania braziliensis are the main
species that cause ATL in Brazil. L. amazonensis is asso-
ciated with the development of localized or diffuse skin
lesions whereas L. braziliensis is associated with localized
cutaneous or mucosal lesions [2–4].
In general, humans or mice infected with L. brazilien-
sis present a stronger cellular immune response against
the parasites than human or mice infected with L. ama-
zonensis [5, 6]. L. braziliensis infections cause small
cutaneous lesions that regress after a few weeks in
C57BL/6 mice. In these mice, it has been demonstrated
that the IL-12-IFN-γ/TNF-α-NO axis controls the parasite
infection [7–9]. By contrast, L. amazonensis generates
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chronic and non-healing infection in C57BL/6 mice
with a deficient Th1 cell response [5, 10].
IL-32 is a cytokine expressed by several human cells,
including NK cells, monocytes/macrophages, T lympho-
cytes, epithelial cells, endothelial cells, fibroblasts and
hepatocytes. IL-32 is predominantly expressed intracel-
lularly and can induce the production of TNF-α, IL-8
and IL-1β [11]. To date, there are nine isoforms of human
IL-32 and the highest biological activity has been attrib-
uted to IL-32γ [12]. IL-32 is associated with the control or
immunopathology of numerous infectious diseases, such
as tuberculosis, HIV/AIDS, leprosy and hepatitis [13] like-
wise in dermatological diseases [14, 15].
Although rodents do not naturally produce IL-32, re-
combinant IL-32 (rIL-32) can activate mouse cells [11].
In addition, injection of rIL-32γ into the knee joints of
mice leads to arthritis partially mediated by induction of
TNF-α [16]. Thus, the use of an experimental animal
model to study the role of IL-32 in inflammatory and in-
fectious diseases is made possible by IL-32 humanized
transgenic mice.
We previously described that cutaneous and mucosal
lesions of patients with ATL caused by L. braziliensis ex-
hibit increased IL-32 expression compared to healthy tis-
sues [17]. Here, we investigated the expression of IL-32 in
cutaneous lesions of patients infected with L. amazonen-
sis, and the role of IL-32γ in experimental mouse infec-
tions caused by L. amazonensis and L. braziliensis.
Methods
Patient and control samples
Patients diagnosed with cutaneous leishmaniasis accord-
ing to Oliveira et al. [8] and control healthy individuals
were submitted to biopsy procedure to obtain frag-
ments from lesions and healthy skin, after signing the
consent form.
Immunohistochemical (IHC) analysis for IL-32
Biopsy fragments were obtained from cutaneous lesions
to identify Leishmania species by polymerase chain re-
action (PCR) as previously described [8], confirming all
samples positive for L. amazonensis. Samples of healthy
skin (n = 8) and a fragment of lesions from patients
(n = 5) were used for IHC analysis for IL-32 using
rabbit polyclonal antibodies to human IL-32 (Abcam
Inc., Cambridge, UK), according to Galdino et al. [17].
The tissue expression (epithelium and dermis) of IL-32
was classified as follows: 0, absence of labelled cells; 1,
1–25% of labelled cells; 2, 26–50% of labelled cells; 3,
51–75% of labelled cells; and 4, 76–100% of labelled
cells). All sections were blindly analyzed using a light
microscope (magnification of 400×).
Animals and parasites
Transgenic mice for human IL-32 were developed by
Choi et al. [18] and donated to our group by Dr.
Charles Dinarello (University of Colorado, Denver,
USA). Six to 8 week old C57BL/6 WT and IL-32γTg
mice were used in the experiments. All procedures
were followed in accordance with the guidelines and le-
gislation on ethics research.
Leishmania (L.) amazonensis (MHOM/BR/1973/
M2269) and L. (V.) braziliensis (MHOM/BR/2003/IMG)
strains were obtained from patients with localized cuta-
neous lesions [19, 20]. L. braziliensis strain was obtained
and identified by our group, as described by Dorta et al.
[19]. Briefly, lesion fragments were macerated in
phosphate-buffered saline (PBS) and cultured in Grace’s
Insect Medium (Gibco, Life Technologies, Carlsbad,
USA) supplemented with heat-inactivated 20% fetal bo-
vine serum (FBS, Sigma-Aldrich, St. Louis, USA) and
100 U/ml of penicillin/streptomycin (Sigma-Aldrich) at
26 °C. The identification of the species was performed
by PCR-RFLP, according to Volpini et al. [21]. Leish-
mania amazonensis strain was identified and donated
to us by Mortara et al. [20].
Leishmania amazonensis and L. braziliensis promasti-
gote forms were cultured in Grace’s insect medium
supplemented as described above. Parasites of either L.
amazonensis or L. braziliensis from stationary phase
(6th day) of growth were washed three times with ster-
ile PBS, pH 7.4 (1000×g, 10 min, 10 °C), suspended in
PBS and quantified by hemocytometer after fixation
with PBS/0.1% formaldehyde.
Parasite lysates were obtained by 5 freeze-thaw cycles
in liquid nitrogen and 37 °C water bath followed by
protein quantification using the Pierce BCA protein
assay (ThermoFisher, Rochester, USA).
Infection, disease progression and histopathological
analysis
Animals were inoculated (1 × 105 promastigotes/10 μl of
PBS) into the dermis of the left ear. Three independent
experiments were performed, with three animals per
group in each experiment. Lesion size was measured
weekly using a digital caliper. Lesion size is described as
the difference between the thickness of the infected ear
and the thickness of the uninfected ear [22]. Tissue para-
sitism was evaluated in the infected ear, draining lymph
node (submandibular) and spleen by limiting dilution
assay. The results were expressed as the negative loga-
rithm of the parasite titer [23]. Paraformaldehyde fixed-
ear tissue was embedded in paraffin to be processed for
histopathological analysis after haematoxylin and eosin
(H&E) staining. The cellular infiltrate evidenced in the
inflammatory process was considered [24–26].
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Cytokine production
Lesion-draining submandibular lymph node cells from
uninfected and infected mice were macerated and
maintained in RMPI 1640 medium (Sigma-Aldrich) sup-
plemented with 10% FBS (Gibco), 1 M HEPES (Sigma-
Aldrich), 2 mM glutamine (Sigma-Aldrich), 100 U/ml
penicillin (Sigma-Aldrich) and 100 μg/ml streptomycin
(Sigma-Aldrich). Viable cells were quantified using a
hemocytometer by dye exclusion with Trypan blue 0.1%
in PBS. Lymph node cells (5 × 105 cells/ml) were stimu-
lated with antigen from L. amazonensis or L. braziliensis
(50 μg/ml) for 24 h or 72 h, at 37 °C and 5% CO2. TNF-
α and IL-10 were evaluated in the culture supernatants
by commercial enzyme-linked immunosorbent assay
(ELISA) kits (R&D Systems, Minneapolis, USA), accord-
ing to the manufacturer’s protocol. IFN-γ was evaluated
by ELISA using monoclonal antibodies obtained from
hybridoma cultures, according to [27]. All cultures and
measurements were done in duplicates.
Statistical analysis
Data are expressed as means ± standard deviations or me-
dian and individual values and compared using Student’s t
or Mann-Whitney U tests, respectively. Analyses were per-
formed using Prism software version 6.0 (GraphPad, San
Diego, CA, USA). Significance was established as P < 0.05.
Results
Expression of IL-32 in lesions of patients with ATL caused
by L. amazonensis
We previously demonstrated that IL-32 is highly
expressed in cutaneous and mucosal lesions of patients
with ATL infected with Leishmania (Viannia) spp., mainly
L. braziliensis. In addition, amastigote forms of L. brazi-
liensis were able to induce IL-32β in human peripheral
blood mononuclear cells [17]. Here, we demonstrate that
in cutaneous lesions caused by L. amazonensis infection
IL-32 protein expression was also increased when com-
pared to healthy skin specimens [U = 7.5, P = 0.0412
(epithelium) and U = 0.0, P = 0.0008 (inflammatory in-
filtrate)]. IL-32 was detected both in the epithelium and
in the inflammatory infiltrate (Fig. 1a, b).
The role of IL-32 in experimental lesions caused by L.
amazonensis or L. braziliensis
To understand the precise role of IL-32 in ATL, we in-
fected human IL-32γTg and WT mice with either L.
amazonensis or L. braziliensis. IL-32γTg mice showed a
delayed development of ear lesions caused by L. amazo-
nensis (until week 3); however, the size of the lesions were
similar to WT mice in later stages of infection (Fig. 2a, c).
In contrast, mice infected with L. braziliensis demon-
strated a significant increase in the lesion size on the 3rd
week of infection (t(14) = 2.23316, P = 0.042), as well as a
reduction of lesion size from week 6 post-infection in IL-
32γTg mice compared to WT mice (Fig. 2b, c) [t(14) =
3.29151, P = 0.0053 (6 weeks); t(14) = 2.16645, P = 0.048
(7 weeks); t14) = 2.82843, P = 0.013 (8 weeks); t(14) =
2.37595, P = 0.032 (9 weeks)].
We observed that L. amazonensis-infected IL-32γTg
mice showed higher lesional parasite load on week 3 of
infection compared to WT animals (t(14) = 2.52036,
P = 0.024). Despite this initial favoring of parasitism in
IL-32γTg animals, the growth of L. amazonensis in later
Fig. 1 Expression of IL-32 in American tegumentary leishmaniasis lesions caused by L. amazonensis. a Fragments of lesions from ATL patients
infected with L. amazonensis and skin from healthy controls were included in paraffin and submitted to immunohistochemistry for IL-32. The
reaction was revealed with 3,3′-Diaminobenzidine and Meyer’s hematoxylin used to counterstain. b Evaluation of IL-32 expression score was
determined according to the percentage of cells expressing IL-32. The scores represent: 0 (absence of stained cells), 1 (1–25% of stained cells),
2 (26–50% stained cells), 3 (51–75% stained cells), and 4 (76–100% stained cells). *P < 0.05 (Mann-Whitney test)
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stages of infection was controlled, whereas parasites grew
exponentially in WT mice (Fig. 2d). Although IL-32γ was
not able to reduce the L. amazonensis infection in the
skin, we observed that IL-32γ is important for parasite dis-
semination because IL-32γTg mice harbored lower num-
bers of L. amazonensis parasites in draining lymph nodes
(t(6) = 3, P = 0.024) and spleens (t(14) = 2.46598, P = 0.027)
compared with WT mice in 9 weeks (Fig. 2e). During L.
braziliensis infection, we observed a strong reduction of
parasite burden in IL-32γTg mice [t(14) = 3.68751,
P = 0.0024 (week 6) and t(14) = 3.12076, P = 0.0075 (week
9)] (Fig. 2f). We did not observe L. braziliensis dissemin-
ation until the end of the experiments. As expected, WT
and IL-32γTg mice exhibited similar histological profiles
of lesional inflammatory infiltrates after L. amazonensis
infection. In contrast, the inflammatory infiltrate was re-
markably reduced on weeks 6 and 9 post-infection in L.
braziliensis-infected IL-32γTg mice compared to WT
mice. Despite this, both WT and IL-32γTg mice showed a
reduction of inflammatory infiltrate at the final stage of in-
fection (9 weeks) when comparing the histopathological
aspects on 3 or 6 weeks (Fig. 3).
IL-32γ induces inflammatory cytokines in experimental
infections caused by L. braziliensis in contrast to L.
amazonensis
Lesion-draining submandibular lymph node cells from
infected mice were stimulated ex vivo with lysates of L.
amazonensis or L. braziliensis promastigotes for 24 h, or
72 h and cytokines were measured in culture supernatants.
No difference in the production of IFN-γ, TNF-α and IL-10
was observed between WT and IL-32γTg animals infected
with L. amazonensis on weeks 3, 6 or 9 post-infection. In
contrast, lymph node cells from L. braziliensis-infected IL-
32γTg animals showed higher cytokine production after
antigen-specific stimulation than cells from WT mice
(weeks 3 and 6; Fig. 4) [t(51) = 3.22153, P = 0.0022 (IFN-γ,
3 weeks); t(54) = 4.87909, P < 0.0001 (TNF-α, 6 weeks);
t(14) = 2.92794, P = 0.011 (IL-10, 6 weeks)].
Discussion
The present study demonstrated that in addition to L.
braziliensis [17], L. amazonensis induces a strong IL-32
expression in human cutaneous lesions. Furthermore, we
showed that human IL-32γ was able to support the heal-
ing of skin lesions in L. braziliensis-infected mice, which is
in contrast to L. amazonensis caused skin lesions. Based
on pro-inflammatory properties of IL-32γ [11, 13] we
hypothesize that IL-32γ could increase the immune re-
sponse against L. amazonensis and lead to improved heal-
ing of the lesions. Although IL-32γ inhibited the lesional
parasite load, IL-32γ did not increase the production of
pro-inflammatory cytokines or improved healing. It is
well-known that L. amazonensis strongly modulates the
host immune response against this parasite [5, 10, 18, 28].
These experimental results, together with the observation
Fig. 2 IL-32 promotes the control of cutaneous infection caused by L. braziliensis, but not caused by L. amazonensis in an ear dermis model. WT
and IL-32γTg mice were infected in the left ear with 1 × 105 L. amazonensis (IFLA/BR/67/PH8) or L. braziliensis (MHOM/BR/2003/IMG) promastigotes in
the stationary phase of growth (6 days of culture). a Ear thickness was monitored weekly, and lesion size was determined by the difference between
infected and uninfected ears. a L. amazonensis infection. b L. braziliensis infection. c Area under the curves is shown for each animal. d Ear parasite
numbers were determined on week 3, 6 and 9 post-infection with L. amazonensis using limiting dilution assays. e Lymph node and spleen parasite
numbers were determined on week 9 post-infection with L. amazonensis. f Ear parasite numbers were determined on week 3, 6 and 9 post-infection
with L. braziliensis using limiting dilution assays. The results presented mean ± standard deviation (8 animals per group). *P < 0.05 (WT × IL-32γTg,
Student’s t-test)
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that IL-32 is highly expressed in cutaneous lesions of L.
amazonensis-infected patients, suggest that even in the
presence of IL-32 the parasites and lesion are persistent.
Although it is known that C57BL/6 mice are relatively
resistant to L. braziliensis infection [5], we observed that
the pro-inflammatory response during L. braziliensis in-
fection was strengthened by IL-32γ without a significant
increase of immunopathology. In addition, IL-32γ played
an important role in controlling the parasite load, favor-
ing the healing of the skin lesion. Thus, in cutaneous
murine lesions caused by L. braziliensis that is restricted
to skin and draining lymph node, the pro-inflammatory
properties of IL-32γ help the control of the infection.
However, in L. amazonensis, which spreads beyond the
cutaneous lesions to other tissues and suppress cytokine
production, IL-32γ contributes to the control of parasite
dissemination but not for skin lesion healing. Differential
expression of IL-32γ in the tissues during these two in-
fections could explain the results besides intrinsic para-
site factors that can interfere with the role of IL-32γ.
The results underscore the need of unravelling the mo-
lecular mechanisms used by L. amazonensis parasites to
subvert the antileishmanial effect of IL-32γ in skin ob-
served against L. braziliensis infection.
It is important to highlight that murine models of
leishmaniasis are not a reliable landscape of the immune
responses against Leishmania parasites because mice do
not produce IL-32. However, murine cells respond to
human IL-32 [12]. Some important microbicidal mecha-
nisms are dependent on IL-32, and therefore these latter
mechanisms are lost in mice [29]. In this way, this IL-
32γTg mouse model is very important to reveal novel
mechanisms that control or lead to immunopathogenesis
in leishmaniasis.
Fig. 3 Histopathological profiles of ear lesions caused by L. amazonensis and L. braziliensis in wild-type and IL-32γTg mice. Fragments of ears from
C57BL/6 WT and IL-32γTg mice uninfected (above) or infected with L. amazonensis (left) or L. braziliensis (right) for 3, 6 and 9 weeks were fixed
and stained by hematoxylin & eosin, for analysis under a light microscope (100× magnification). A mononuclear cell inflammatory infiltrate was
observed in the dermis that was progressive in L. amazonensis-infected and regressive in L. braziliensis-infected mice. Scale-bars: 100 μm
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Conclusions
IL-32γ is an important player in the control of L. brazi-
liensis cutaneous infections in contrast to L. amazonensis-
mediated infections, at least in ear dermis infection model.
IL-32γ might be a novel target in strategies to control
leishmaniasis caused by L. braziliensis.
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